Generalised anxiety and panic symptoms in the German National Cohort (NAKO)

References

• Alonso J, Lépine JP. 2007. Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry. 68(Suppl. 2):3–9.
   PubMed Web of Science ®Google Scholar
• Altunoz U, Kokurcan A, Kirici S, Bastug G, Ozel-Kizil ET. 2018. Clinical characteristics of generalized anxiety disorder: older vs. young adults. Nord J Psychiatry. 72(2):97–102.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. Diagnostical and statistical manual of mental disorders (DSM-IV).
   Google Scholar
• Bandelow B, Michaelis S. 2015. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 17(3):327–335.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Schüller K. 2020. Mean age and gender distribution of patients with major mental disorders participating in clinical trials. Eur Arch Psychiatry Clin Neurosci. 270(6):655–659.
   PubMed Web of Science ®Google Scholar
• Barzilay R, White LK, Moore TM, Calkins ME, Taylor JH, Patrick A, Huque ZM, Young JF, Ruparel K, Pine DS, et al. 2020. Association of anxiety phenotypes with risk of depression and suicidal ideation in community youth. Depress Anxiety. 37(9):851–861.
   PubMed Web of Science ®Google Scholar
• Batelaan NM, De Graaf R, Penninx BWJH, Van Balkom AJLM, Vollebergh WAM, Beekman ATF. 2010. The 2-year prognosis of panic episodes in the general population. Psychol Med. 40(1):147–157.
   PubMed Web of Science ®Google Scholar
• Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA. 2014. The global burden of anxiety disorders in 2010. Psychol Med. 44(11):2363–2374.
   PubMed Web of Science ®Google Scholar
• Beesdo K, Pine DS, Lieb R, Wittchen HU. 2010. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry. 67(1):47–57.
   PubMed Web of Science ®Google Scholar
• Bereza BG, Machado M, Einarson TR. 2009. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clin Ther. 31(6):1279–1308.
   PubMed Web of Science ®Google Scholar
• Berger K, Rietschel M, Rujescu D. 2022. The value of "mega cohorts" for psychiatric research. World J Biol Psychiatry. doi:10.1080/15622975.2021.2011405
   Web of Science ®Google Scholar
• Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, et al. 2003. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abus Negl. 27(2):169–190.
   PubMed Web of Science ®Google Scholar
• Beutel ME, Jünger C, Klein EM, Wild P, Lackner KJ, Blettner M, Banerjee M, Michal M, Wiltink J, Brähler E. 2016. Depression, anxiety and suicidal ideation among 1st and 2nd generation migrants – results from the Gutenberg health study. BMC Psychiatry. 16(1):2.
   PubMedGoogle Scholar
• Blackmore R, Boyle JA, Fazel M, Ranasinha S, Gray KM, Fitzgerald G, Misso M, Gibson-Helm M. 2020. The prevalence of mental illness in refugees and asylum seekers: a systematic review and meta-analysis. PLoS Med. 17(9):e1003337–24.
   PubMed Web of Science ®Google Scholar
• Boehlen FH, Herzog W, Schellberg D, Maatouk I, Schoettker B, Brenner H, Wild B. 2020. Gender-specific predictors of generalized anxiety disorder symptoms in older adults: results of a large population-based study. J Affect Disord. 262:174–181.
   PubMed Web of Science ®Google Scholar
• Carter RM, Wittchen HU, Pfister H, Kessler RC. 2001. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety. 13(2):78–88.
   PubMed Web of Science ®Google Scholar
• Cervilla JA, Gutiérrez B, Rodríguez-Barranco M, Ibanez-Casas I, Pérez-García M, Valmisa E, Carmona J, Molina E, Moreno-Kustner B, Rivera M, et al. 2018. A cross-sectional study on the prevalence and risk correlates of mental disorders: the GRANADΣP study. J Nerv Ment Dis. 206(9):716–725.
   PubMed Web of Science ®Google Scholar
• Chen MH, Tsai SJ. 2016. Treatment-resistant panic disorder: clinical significance, concept and management. Prog Neuropsychopharmacol Biol Psychiatry. 70:219–226.
   PubMed Web of Science ®Google Scholar
• Consortium GNC (GNC). 2014. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 29:371–382.
   PubMed Web of Science ®Google Scholar
• Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, Wittchen HU. 2017. Anxiety disorders. Nat Rev Dis Prim. 2017:3.
   Google Scholar
• Deacon B, Lickel J, Abramowitz JS. 2008. Medical utilization across the anxiety disorders. J Anxiety Disord. 22(2):344–350.
   PubMed Web of Science ®Google Scholar
• Deckert J, Erhardt A. 2019. Predicting treatment outcome for anxiety disorders with or without comorbid depression using clinical, imaging and (epi)genetic data. Curr Opin Psychiatry. 32(1):1–6.
   PubMed Web of Science ®Google Scholar
• Dragano N, Reuter M, Greiser KH, Becher H, Zeeb H, Mikolajczyk R, Kluttig A, Leitzmann M, Fischer B, Jöckel KH, et al. 2020. Socio-demographic and employment-related factors in the German National Cohort (GNC; NAKO Gesundheitsstudie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 63(3):267–278.
   PubMed Web of Science ®Google Scholar
• Ford JD, Trestman RL, Steinberg K, Tennen H, Allen S. 2004. Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Soc Sci Med. 58(11):2145–2148.
   PubMed Web of Science ®Google Scholar
• Gadermann AM, Alonso J, Vilagut G, Zaslavsky AM, Kessler RC. 2012. Comorbidity and disease burden in the national comorbidity survey replication (NCS-R). Depress Anxiety. 29(9):797–806.
   PubMed Web of Science ®Google Scholar
• Glaesmer H, Schulz A, Häuser W, Freyberger HJ, Brähler E, Grabe H-J. 2013. Der Childhood Trauma Screener (CTS) - Entwicklung und Validierung von Schwellenwerten zur Klassifikation [The childhood trauma screener (CTS) - development and validation of cut-off-scores for classificatory diagnostics]. Psychiat Prax. 40(4): 220–226.
   PubMed Web of Science ®Google Scholar
• Gräfe K, Zipfel S, Herzog W, Löwe B. 2004. Screening psychischer störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Ergebnisse der Deutschen validierungsstudie. Diagnostica. 50(4):171–181.
   Web of Science ®Google Scholar
• Hajek A, König HH. 2020. Prevalence and correlates of individuals screening positive for depression and anxiety on the phq-4 in the german general population: findings from the nationally representative german socio-economic panel (GSOEP). Int J Environ Res Public Health. 17(21):7865–7811.
   PubMed Web of Science ®Google Scholar
• Hendriks SM, Spijker J, Licht CMM, Hardeveld F, de Graaf R, Batelaan NM, Penninx BWJH, Beekman ATF. 2016. Long-term disability in anxiety disorders. BMC Psychiatry. 16(1):946.
   Google Scholar
• Hinz A, Klein AM, Brähler E, Glaesmer H, Luck T, Riedel-Heller SG, Wirkner K, Hilbert A. 2017. Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord. 210:338–344.
   PubMed Web of Science ®Google Scholar
• Horenstein A, Heimberg RG. 2020. Anxiety disorders and healthcare utilization: a systematic review. Clin Psychol Rev. 81:101894.
   PubMed Web of Science ®Google Scholar
• Ikic V, Bélanger C, Bouchard S, Gosselin P, Langlois F, Labrecque J, Dugas MJ, Marchand A. 2017. Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder. J Ment Health Policy Econ. 20(1):11–20.
   PubMed Web of Science ®Google Scholar
• Johansson R, Carlbring P, Heedman Å, Paxling B, Andersson G. 2013. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ. 1(1):e98–18.
   PubMedGoogle Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 62(6):593–602.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. 2012. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 21(3):169–184.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Wai TC, Jin R, Ruscio AM, Shear K, Walters EE. 2006. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 63(4):415–424.
   PubMed Web of Science ®Google Scholar
• Kleineidam L, Stark M, Riedel-Heller SG, Pabst A, Schmiedek F, Streit F, Rietschel M, Klinger-König J, Grabe HJ, Erhardt A, et al. 2022. The assessment of cognitive function in the German National Cohort (NAKO) - Associations of demographics and psychiatric symptoms with cognitive test performance. World J Biol Psychiatry. doi:10.1080/15622975.2021.2011408
   Google Scholar
• Klinitzke G, Romppel M, Häuser W, Brähler E, Glaesmer H. 2012. [The German Version of the Childhood Trauma Questionnaire (CTQ): psychometric characteristics in a representative sample of the general population]. Psychother Psychosom Med Psychol. 62(2):47–51.
   PubMed Web of Science ®Google Scholar
• Klinger-König J, Streit F, Erhardt-Lehmann A, Kleineidam L, Schmiedek F, Schmidt B, NAKO Investigators, Wagner M, Deckert J, Rietschel M, Berger K, et al. 2022. The assessment of childhood maltreatment and its associations with affective symptoms in adulthood: results of the German National Cohort (NAKO). World J Biol Psychiatry. doi:10.1080/15622975.2021.2011406
   Web of Science ®Google Scholar
• Kohn R, Saxena S, Levav I, Saraceno B. 2004. The treatment gap in mental health care. Bull World Health Organ. 82(11):858–866.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. 2001. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. 2007. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 146(5):317–325.
   PubMed Web of Science ®Google Scholar
• Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY. 2008. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 46(3):266–274.
   PubMed Web of Science ®Google Scholar
• Marques L, Robinaugh DJ, Leblanc NJ, Hinton D. 2011. Cross-cultural variations in the prevalence and presentation of anxiety disorders. Expert Rev Neurother. 11(2):313–322.
   PubMed Web of Science ®Google Scholar
• Moffitt TE, Harrington HL, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R. 2007. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 64(6):651–660.
   PubMed Web of Science ®Google Scholar
• Moreno-Peral P, Bellón JÁ, Motrico E, Campos-Paíno H, Martín-Gómez C, Ebert DD, Buntrock C, Roca M, Conejo-Cerón S. 2020. Moderators of psychological and psychoeducational interventions for the prevention of anxiety: a systematic review. J Anxiety Disord. 76:102317.
   PubMed Web of Science ®Google Scholar
• Muñoz-Navarro R, Cano-Vindel A, Wood CM, Ruíz-Rodríguez P, Medrano LA, Limonero JT, Tomás-Tomás P, Gracia-Gracia I, Dongil-Collado E, Iruarrizaga MI. 2016. The PHQ-PD as a screening tool for panic disorder in the primary care setting in Spain. PLoS One. 11(8):e0161145.
   PubMed Web of Science ®Google Scholar
• Ninan PT, Dunlop BW. 2005. Neurobiology and etiology of panic disorder. J Clin Psychiatry. 66(Suppl. 4):3–7.
   PubMedGoogle Scholar
• Nugent NR, Tyrka AR, Carpenter LL, Price LH. 2011. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology. 214(1):175–196.
   PubMed Web of Science ®Google Scholar
• Parkerson HA, Thibodeau MA, Brandt CP, Zvolensky MJ, Asmundson GJG. 2015. Cultural-based biases of the GAD-7. J Anxiety Disord. 31:38–42.
   PubMed Web of Science ®Google Scholar
• Pignon B, Amad A, Pelissolo A, Fovet T, Thomas P, Vaiva G, Roelandt JL, Benradia I, Rolland B, Geoffroy PA. 2018. Increased prevalence of anxiety disorders in third-generation migrants in comparison to natives and to first-generation migrants. J Psychiatr Res. 102:38–43.
   PubMed Web of Science ®Google Scholar
• Plummer F, Manea L, Trepel D, McMillan D. 2016. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 39:24–31.
   PubMed Web of Science ®Google Scholar
• Rayner C, Coleman JRII, Purves KL, Hodsoll J, Goldsmith K, Alpers GW, Andersson E, Arolt V, Boberg J, Bögels S, et al. 2019. A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders. Transl Psychiatry. 9(1):150.
   PubMedGoogle Scholar
• Revicki DA, Travers K, Wyrwich KW, Svedsäter H, Locklear J, Mattera MS, Sheehan DV, Montgomery S. 2012. Humanistic and economic burden of generalized anxiety disorder in North America and Europe. J Affect Disord. 140(2):103–112.
   PubMed Web of Science ®Google Scholar
• Rief W, Nanke A, Klaiberg A, Braehler E. 2004. Base rates for panic and depression according to the Brief Patient Health Questionnaire: a population-based study. J Affect Disord. 82(2):271–276.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC. 2000. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry. 176:229–235.
   PubMed Web of Science ®Google Scholar
• Ruiz MA, Zamorano E, García-Campayo J, Pardo A, Freire O, Rejas J. 2011. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disord. 128(3):277–286.
   PubMed Web of Science ®Google Scholar
• Schipf S, Schöne G, Schmidt B, Günther K, Stübs G, Greiser KH, Bamberg F, Meinke-Franze C, Becher H, Berger K, et al. 2020. [The baseline assessment of the German National Cohort (NAKO Gesundheitsstudie): participation in the examination modules, quality assurance, and the use of secondary data]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 63(3):254–266.
   PubMed Web of Science ®Google Scholar
• Schmiedek F, Kröhne U, Goldhammer F, Prindle JJ, Lindenberger U, NAKO Investigators, Wagner M, Berger K. 2022. General cognitive ability assessment in the German National Cohort – The block-adaptive number series task. World J Biol Psychiatry. doi:10.1080/15622975.2021.2011407
   Web of Science ®Google Scholar
• Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Il Shin J, Kirkbride JB, Jones P, Kim JH, et al. 2021. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2021:7.
   Google Scholar
• Spitzer RL, Kroenke K, Williams JBW. 1999. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. J Am Med Assoc. 282(18):1737–1744.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, Löwe B. 2006. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 166(10):1092–1097.
   PubMed Web of Science ®Google Scholar
• Stein MB. 2009. The neurobiology of generalized anxiety disorder. J Clin Psychiatry. 70(Suppl 2):15–19.
   PubMedGoogle Scholar
• Streit F, Zillich L, Frank J, Kleineidam L, Wagner M, Baune BT, Klinger-König J, Grabe HJ, Pabst A, Riedel-Heller SG, et al. 2022. Lifetime and current depression in the German National Cohort (NAKO). World J Biol Psychiatry. doi: 10.1080/15622975.2021.2014152.
   Web of Science ®Google Scholar
• Sydsjö G, Agnafors S, Bladh M, Josefsson A. 2018. Anxiety in women – a Swedish national three-generational cohort study. BMC Psychiatry. 18(1):712.
   Google Scholar
• Ter Meulen WG, Draisma S, van Hemert A, Schoevers R, Kupka R, Beekman A, Penninx B. 2021. Depressive and Anxiety Disorders in concert-A synthesis of findings on comorbidity in the NESDA study. J Affect Disord. 284:85–97.
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Simpson W, Patterson B, Mancini C. 2013. Panic attacks in generalized anxiety disorder. J Nerv Ment Dis. 201(1):52–55.
   PubMed Web of Science ®Google Scholar
• Watterson RA, Williams JVA, Lavorato DH, Patten SB. 2017. Descriptive epidemiology of generalized anxiety disorder in Canada. Can J Psychiatry. 62(1):24–29.
   PubMed Web of Science ®Google Scholar
• Weisberg RB. 2009. Overview of generalized anxiety disorder: epidemiology, presentation, and course. J Clin Psychiatry. 70(Suppl 2):4–9.
   PubMedGoogle Scholar
• Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. 2000. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 15(6):319–328.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Jacobi F. 2005. Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 15(4):357–376.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, et al. 2011. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 21(9):655–679.
   PubMed Web of Science ®Google Scholar